×

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

  • US 10,532,091 B1
  • Filed: 07/10/2019
  • Issued: 01/14/2020
  • Est. Priority Date: 08/05/2015
  • Status: Active Grant
First Claim
Patent Images

1. A method of eliciting an immune response in a patient who has cancer, comprising administering to said patient a population of activated T cells that kill cancer cells that present a peptide consisting of the amino acid sequence selected from SEQ ID NO:

  • 24,wherein said cancer is selected from liver cancer, benign prostate hyperplasia, and prostate cancer.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×